Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Lipocine Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +5 vs. Q4 2021
- Shares held
- 11.9M
- +1.30M (+12.2%) vs. Q4 2021
- Total value
- $16.2M
- +$5.64M (+53.6%) vs. Q4 2021
- New holders
- 9
- 13 more added
- Sold out
- 4
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,797,282 | $5.20M | 0.00% | −12,688−0.3% | Reduced |
| BlackRock Inc. | 1,564,692 | $2.14M | 0.00% | −29,855−1.9% | Reduced |
| Wealth Effects LLC | 1,490,834 | $2.04M | 0.95% | +1,400+0.1% | Added |
| Geode Capital Management, LLC | 823,055 | $1.13M | 0.00% | −1,379−0.2% | Reduced |
| EAM Investors, LLC | 657,804 | $901.0K | 0.17% | +657,804 | New |
| Marshall Wace, LLP | 562,670 | $771.0K | 0.00% | +562,670 | New |
| Two Sigma Investments, LP | 360,070 | $493.0K | 0.00% | +257,470+250.9% | Added |
| State Street Corp | 327,405 | $449.0K | 0.00% | +22,788+7.5% | Added |
| Mercer Global Advisors Inc | 309,111 | $423.0K | 0.00% | −4,000−1.3% | Reduced |
| Kestra Advisory Services, LLC | 307,300 | $421.0K | 0.00% | +67,000+27.9% | Added |
| Price T Rowe Associates Inc | 184,662 | $253.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 176,864 | $242.0K | 0.00% | +176,864 | New |
| Northern Trust Corp | 168,225 | $230.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 142,400 | $195.0K | 0.00% | +89,400+168.7% | Added |
| Virtu Financial LLC | 124,550 | $171.0K | 0.01% | +7,064+6.0% | Added |
| Goldman Sachs Group Inc | 88,615 | $121.0K | 0.00% | +74,428+524.6% | Added |
| MML Investors Services, LLC | 77,000 | $105.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 70,250 | $96.0K | 0.00% | +7,500+12.0% | Added |
| Ameriprise Financial Inc | 66,500 | $91.0K | 0.00% | 00.0% | Unchanged |
| RSM US Wealth Management LLC | 65,212 | $89.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 63,135 | $86.0K | 0.00% | +27,530+77.3% | Added |
| Bank of New York Mellon Corp | 55,204 | $76.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 50,000 | $69.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 40,823 | $55.0K | 0.00% | −185,425−82.0% | Reduced |
| XTX Topco Ltd | 39,357 | $54.0K | 0.02% | +39,357 | New |
| Jane Street Group, LLC | 30,759 | $42.0K | 0.00% | +8,121+35.9% | Added |
| Susquehanna International Group, LLP | 29,899 | $41.0K | 0.00% | −135,078−81.9% | Reduced |
| Moloney Securities Asset Management, LLC | 22,500 | $31.0K | 0.01% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 18,905 | $26.0K | 0.00% | +18,905 | New |
| Plante Moran Financial Advisors, LLC | 17,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 13,900 | $19.0K | 0.00% | +900+6.9% | Added |
| Renaissance Technologies LLC | 14,100 | $19.0K | 0.00% | +14,100 | New |
| Creative Planning | 10,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,554 | $12.0K | 0.00% | +5,995+234.3% | Added |
| UBS Group AG | 7,362 | $10.0K | 0.00% | +3,362+84.1% | Added |
| Wells Fargo & Company | 3,543 | $5.00K | 0.00% | −569−13.8% | Reduced |
| JPMorgan Chase & Co | 3,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,000 | $1.00K | 0.00% | −167−14.3% | Reduced |
| Citigroup Inc | 500 | $1.00K | 0.00% | +500 | New |
| FMR LLC | 140 | $0 | 0.00% | −46−24.7% | Reduced |
| Walleye Trading LLC | 101 | $0 | 0.00% | +101 | New |
| Aaron Wealth Advisors | 117,552 | – | – | +117,552 | New |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −440,432−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,180−100.0% | Sold out |
| Pinnacle Private Wealth, LLC | 0 | $0 | 0.00% | −15,250−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,715−100.0% | Sold out |